Hot Topics

(Image: Getty/CIPhotos)

Shire sells cancer biz for $2.4bn

By Flora Southey

Shire has sold its oncology business to French firm Servier S.A.S as it looks to better align its long-term strategy.

GettyImage/marchmeena29

“We need Big Pharma and we are getting Big Pharma,” says Dyadic

Dyadic confident Big Biopharma will move away from CHO cell reliance

By Dan Stanton

Dyadic International says a string of deals shows biopharma is beginning to embrace its low-cost and high-yielding – yet commercially unproven – fungus-based expression platform.